Simplifying the transition from R&D to GMP-ready LNP production
On demand

Simplifying the transition from R&D to GMP-ready LNP production

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Simplifying the transition from R&D to GMP-ready LNP production

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

Lipid nanoparticle (LNP) production processes often face significant hurdles during the transition from R&D to GMP environments. Equipment changes lead to resource wastage and taxing process revalidation, posing a number of challenges in terms of efficiently and successfully making the move to the next phase of development.

This webinar will provide insights into a solution for successful transition to GMP production of LNPs, including GMP-compliant touchscreen-operated software, and a fully traceable, fully replaceable wetted flow path backed up with extractables data.

The Sunbather simplifies the transition to GMP by retaining the same pumping and mixing technologies as Sunshine, the all-around LNP process developer. By ensuring consistency, process transfer or re-optimization are not necessary, allowing an easy transition into GMP production of up to 1.8 liters of LNPs per hour.

Jon this webinar to learn about:

  • Solutions for a simple and consistent transition to GMP production of LNPs
  • The key features and benefits of the Sunbather system
  • Direct process transfer from screening through to GMP
Benjamin Knappett
Benjamin Knappett
Market Manager, LNPs at Unchained Labs
Ben Knappett received his MChem degree from Durham University and completed a PhD in nanoparticle synthesis and characterization at the University of Cambridge. Ben started working for Particle Works in 2016, developing nanoparticle and microparticle products using microfluidics technology, which covered a wide range of material types. Ben moved to the position as the Head of Science and Applications when the Particle Works brand relaunched in 2021 as a provider of automated nanoparticle synthesis platforms. Following the acquisition of Particle Works to Unchained Labs, Ben undertakes the role of Product Manager – LNP Solutions, focusing on delivery of automated, high-throughput solutions for LNP encapsulation in drug delivery, vaccines, and gene therapy.